Teva Jumps on Move Into Branded Drugs: Israel Overnight

Teva Pharmaceutical Industries Ltd. surged to a two-month high in New York as the purchase of a new treatment signaled the world’s largest generic drugmaker will seek to boost profit by moving into branded medicines.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.